STAR LAKE BIOSCIENCE CO., INC.ZHAOQING GUANGDONG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.09 CNY | -1.74% |
|
+22.65% | +9.23% |
| Apr. 23 | China stocks down, dragged by cyclical shares; HK shares up | RE |
| Apr. 22 | Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 17.49B 2.41B | Sales 2023 | 17.37B 2.4B | Capitalization | 7.74B 1.07B |
|---|---|---|---|---|---|
| Net income 2022 | 608M 83.91M | Net income 2023 | 678M 93.57M | EV / Sales 2022 | 0.76 x |
| Net Debt 2022 | 3.45B 476M | Net Debt 2023 | 2.79B 384M | EV / Sales 2023 | 0.61 x |
| P/E ratio 2022 |
11.6
x | P/E ratio 2023 |
11.4
x | Employees | 8,908 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.79% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.74% | ||
| 1 week | +22.65% | ||
| Current month | +17.82% | ||
| 1 month | +18.37% | ||
| 3 months | +15.42% | ||
| 6 months | +0.59% | ||
| Current year | +9.23% |
1 week
4.18
5.34
1 month
3.815.34
Current year
3.355.34
1 year
3.356.08
3 years
3.359.34
5 years
3.359.34
10 years
2.899.65
| Managers | Title | Age | Since |
|---|---|---|---|
Jun Ying
CEO | Chief Executive Officer | 51 | 19-09-23 |
Jun Lai Chen
DFI | Director of Finance/CFO | 49 | 21-10-14 |
Xiao Long Yan
BRD | Director/Board Member | 51 | 23-09-12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lei Zhang
BRD | Director/Board Member | 55 | 13-09-17 |
Wu Chen
BRD | Director/Board Member | 56 | 11-01-31 |
Rong Dan Xu
DFI | Director of Finance/CFO | 48 | 20-02-13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 5.09 | -1.74% | 92,274,610 |
| 24-04-24 | 5.18 | +8.14% | 151,016,900 |
| 24-04-23 | 4.79 | +10.11% | 8,337,658 |
| 24-04-22 | 4.35 | +4.32% | 16,474,530 |
| 24-04-19 | 4.17 | +0.48% | 9,163,014 |
End-of-day quote Shanghai S.E., April 24, 2024
More quotes
STAR LAKE BIOSCIENCE CO., INC. ZHAOQING GUANGDONG is a China-based company principally engaged in the bio-chemical and bio-fermentation business. The Company's principal products are biochemical drugs, feed additives and food additives, including nucleotide additives, amino acid feed additives, nucleoside and nucleotide bulk pharmaceutical chemicals (BPCs), as well as amino acid BPC and intermediates. The Company mainly sells its products in domestic and overseas markets.
Sector
Food Processing
Calendar
2024-05-12
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +9.23% | 1.17B | |
| +0.29% | 29.21B | |
| +4.16% | 21.53B | |
| +13.39% | 11.86B | |
| +12.98% | 5.17B | |
| +9.95% | 4.17B | |
| -18.33% | 3.4B | |
| -4.25% | 3.15B | |
| +3.67% | 3.08B | |
| +27.19% | 2.79B |
- Stock Market
- Equities
- 600866 Stock
